atai and Beckley Psytech plan to meet with the U.S. Food and Drug Administration (FDA) and other regulatory agencies to finalize the Phase 3 trial design.
Opaganib has shown potential in enhancing ARPI treatment by blocking multiple enzymes involved in cancer cell survival.
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
New findings reveal bemarituzumab plus chemotherapy significantly improves survival in advanced gastric cancer, offering hope for targeted treatment options
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
The inspection concluded with zero Form 483 observations
The NovaSeq X system features Illumina's cutting-edge XLEAP-SBS chemistry, offering unmatched throughput, accuracy, and sustainability
This collaboration ensures that patients receive comprehensive care, including emotional and psychological support throughout their fertility journey
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
The GMP-compliant facility with automated environmental monitoring accommodates both white room and class 7 and 8 cleanroom space
Subscribe To Our Newsletter & Stay Updated
